Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1999-2-23
pubmed:abstractText
The human glucagon-like peptide-1 (GLP-1) receptor mediates the insulinotropic effects of the incretin hormone GLP-1. It is expressed in a cell- and tissue-specific manner. Recently, we cloned the 5'-region of the GLP-1 receptor gene and found that tissue and cell specificity is lost by 5'-deletion to -574. In this region proximal to the main transcription start point three putative binding sites for Sp1 were localized. Now, in vitro binding of Sp1 was shown by deoxyribonuclease footprint analysis with DNA fragments using either recombinant Sp1 or nuclear extracts from HIT cells. To elucidate the roles of the three Sp1-binding sites, we mutated each of the sites individually as well as in different combinations. The activity of each construct was analyzed in comparison to the wild-type promoter. Mutation of two adjacent Sp1-binding sites showed a clear reduction of activity. Contrasting results were obtained after mutation of the third, more distal Sp1-binding site. Here, a clear increase (approximately 150%) revealed a silencing effect of this cis-regulatory element, possibly resembling a Sp3-binding site. Electrophoretic mobility shift analysis revealed binding of Sp1 and Sp3, which was demonstrated by supershifts using specific antibodies. Cotransfection with Sp1 and Sp3 expression vectors in insect cells lacking endogenous Sp factors clearly demonstrated the involvement of Sp1 and Sp3. Therefore, the basal activity of the GLP-1 receptor gene is mediated by two proximal Sp1-binding sites, whereas a more distal site acts as a repressor.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0013-7227
pubmed:author
pubmed:issnType
Print
pubmed:volume
140
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
624-31
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:9927286-Animals, pubmed-meshheading:9927286-Base Sequence, pubmed-meshheading:9927286-Binding Sites, pubmed-meshheading:9927286-Blotting, Western, pubmed-meshheading:9927286-Cell Line, pubmed-meshheading:9927286-DNA Footprinting, pubmed-meshheading:9927286-DNA-Binding Proteins, pubmed-meshheading:9927286-Drosophila melanogaster, pubmed-meshheading:9927286-Electrophoresis, pubmed-meshheading:9927286-Gene Expression Regulation, pubmed-meshheading:9927286-Humans, pubmed-meshheading:9927286-Molecular Sequence Data, pubmed-meshheading:9927286-Mutation, pubmed-meshheading:9927286-Plasmids, pubmed-meshheading:9927286-Promoter Regions, Genetic, pubmed-meshheading:9927286-Receptors, Glucagon, pubmed-meshheading:9927286-Sp1 Transcription Factor, pubmed-meshheading:9927286-Sp3 Transcription Factor, pubmed-meshheading:9927286-Transcription Factors, pubmed-meshheading:9927286-Transfection
pubmed:year
1999
pubmed:articleTitle
Gene expression of the human glucagon-like peptide-1 receptor is regulated by Sp1 and Sp3.
pubmed:affiliation
Department of Internal Medicine, Philipps University of Marburg, Germany.
pubmed:publicationType
Journal Article